Spyre Therapeutics
SYRE
SYRE
107 hedge funds and large institutions have $1.18B invested in Spyre Therapeutics in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 17 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 103 → 107 (+4)
2% less capital invested
Capital invested by funds: $1.21B → $1.18B (-$29.2M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
107
Holding in Top 10
3
Calls
$61K
Puts
$35K
Top Buyers
| 1 | +$85.6M | |
| 2 | +$47M | |
| 3 | +$43.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$30M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$12.1M | |
| 3 | -$9.48M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$6.14M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.85M |